BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET
Aug 17, 2023
AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable
Aug 16, 2023
Americans from Across the Political Spectrum Want Congress to Pass Bipartisan… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, ASTRAZENECA, AMGEN, ELI LILLY
Aug 14, 2023
Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of… Read More
CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION
Aug 9, 2023
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for… Read More
ICYMI: Business Insider: “Big Pharma’s Big Tax Dodge”
Aug 9, 2023
International Experts Slam Big Pharma’s Egregious Offshoring Scam of U.S. Read More
BIG PHARMA EARNINGS WATCH: PFIZER & MERCK
Aug 7, 2023
More Q2 2023 Earnings Reports Demonstrate Big Pharma Firms Top Wall Street… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE & ABBVIE
Aug 3, 2023
Big Pharma Giants Boast Better Than Expected Q2 Earnings While Price-Gouging… Read More
BIG PHARMA WATCH: COLOSSAL $81.9 BILLION IN 2022 EARNINGS FOR LARGEST DRUG MAKERS FUELED HUGE PROFITS
Jul 25, 2023
Top Five Drug Makers By U.S. Market Cap Plowed Soaring Earnings Into Stock… Read More
BIG PHARMA WATCH: DRUG MAKER’S PRODUCT-HOPPING SCHEME BLOCKED ACCESS TO SAFER HIV MEDICATIONS TO JUICE PROFITS
Jul 24, 2023
The New York Times Exposes How Gilead Devised Egregious Patent Strategy to… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS & JOHNSON & JOHNSON
Jul 20, 2023
Big Pharma Giants Kick Off Q2 Earnings On Heels of July Price Hikes This week,… Read More
CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE
Jul 18, 2023
Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to… Read More
BIG PHARMA WATCH: HHS SECRETARY WARNS COVID-19 VACCINE MAKERS OVER “PRICE-GOUGING BEHAVIOR”
Jul 14, 2023
Becerra Encourages Manufacturers to Set “Reasonable” Prices on Upcoming… Read More